Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 3639868, 18 pages
http://dx.doi.org/10.1155/2016/3639868
Research Article

Cilostazol Improves Proangiogenesis Functions in Human Early Endothelial Progenitor Cells through the Stromal Cell-Derived Factor System and Hybrid Therapy Provides a Synergistic Effect In Vivo

1Department of Biological Science, National Sun Yat-Sen University, Kaohsiung 704, Taiwan
2Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan 804, Taiwan

Received 28 March 2016; Accepted 8 June 2016

Academic Editor: Jörn Tongers

Copyright © 2016 Shih-Ya Tseng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. H. Annex, “Therapeutic angiogenesis for critical limb ischaemia,” Nature Reviews Cardiology, vol. 10, no. 7, pp. 387–396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. T.-H. Chao, I.-C. Chen, S.-Y. Tseng, and Y.-H. Li, “Pluripotent stem cell therapy in ischemic cardiovascular disease,” Acta Cardiologica Sinica, vol. 30, no. 5, pp. 365–374, 2014. View at Google Scholar · View at Scopus
  3. J. Furmston, A. S. Patel, F. Ludwinski et al., “Angiogenic cell therapy for critical limb ischemia: an update on concepts and trials,” Journal of Cardiovascular Surgery, vol. 55, no. 5, pp. 641–654, 2014. View at Google Scholar · View at Scopus
  4. T.-H. Chao, S.-Y. Tseng, Y.-H. Li et al., “A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade,” Clinical Science, vol. 123, no. 3, pp. 147–159, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. D. W. Losordo and S. Dimmeler, “Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines,” Circulation, vol. 109, no. 21, pp. 2487–2491, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Chen, F. Wu, W.-H. Xia et al., “CXCR4 gene transfer contributes to in vivo reendothelialization capacity of endothelial progenitor cells,” Cardiovascular Research, vol. 88, no. 3, pp. 462–470, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Asahara, H. Masuda, T. Takahashi et al., “Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization,” Circulation Research, vol. 85, no. 3, pp. 221–228, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. J.-I. Yamaguchi, K. F. Kusano, O. Masuo et al., “Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization,” Circulation, vol. 107, no. 9, pp. 1322–1328, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. D. H. Walter, U. Rochwalsky, J. Reinhold et al., “Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 2, pp. 275–282, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Marsboom and S. Janssens, “Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies,” Expert Review of Cardiovascular Therapy, vol. 6, no. 5, pp. 687–701, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S.-Y. Tseng, T.-H. Chao, Y.-H. Li et al., “Cilostazol improves high glucose-induced impaired angiogenesis in human endothelial progenitor cells and vascular endothelial cells as well as enhances vasculoangiogenesis in hyperglycemic mice mediated by the adenosine monophosphate-activated protein kinase pathway,” Journal of Vascular Surgery, vol. 63, no. 4, pp. 1051–1062.e3, 2016. View at Publisher · View at Google Scholar
  13. C. Lugnier, “Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents,” Pharmacology & Therapeutics, vol. 109, no. 3, pp. 366–398, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J.-H. Lim, J.-S. Woo, and Y.-W. Shin, “Cilostazol protects endothelial cells against lipopolysaccharide-induced apoptosis through ERK1/2- and P38 MAPK-dependent pathways,” The Korean Journal of Internal Medicine, vol. 24, no. 2, pp. 113–122, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. T.-H. Chao, S.-Y. Tseng, I.-C. Chen et al., “Cilostazol enhances mobilization and proliferation of endothelial progenitor cells and collateral formation by modifying vasculo-angiogenic biomarkers in peripheral arterial disease,” International Journal of Cardiology, vol. 172, no. 2, pp. e371–e374, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Biscetti, G. Pecorini, G. Straface et al., “Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism,” International Journal of Cardiology, vol. 167, no. 3, pp. 910–916, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Kalka, H. Masuda, T. Takahashi et al., “Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 7, pp. 3422–3427, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Barnett, G. Janossy, A. Lubenko et al., “Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Prepared by the CD34+ haematopoietic stem cell working party. General Haematology Task Force of the British Committee for Standards in Haematology,” Clinical and Laboratory Haematology, vol. 21, no. 5, pp. 301–308, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Orimo, P. B. Gupta, D. C. Sgroi et al., “Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion,” Cell, vol. 121, no. 3, pp. 335–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Miyashita, H. Itoh, H. Arai et al., “The neuroprotective and vasculo-neuro-regenerative roles of adrenomedullin in ischemic brain and its therapeutic potential,” Endocrinology, vol. 147, no. 4, pp. 1642–1653, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Yamahara and H. Itoh, “Potential use of endothelial progenitor cells for regeneration of the vasculature,” Therapeutic Advances in Cardiovascular Disease, vol. 3, no. 1, pp. 17–27, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-H. Wang, P.-H. Huang, J.-W. Chen et al., “Clinical application of endothelial progenitor cell: are we ready?” Acta Cardiologica Sinica, vol. 29, no. 6, pp. 479–487, 2013. View at Google Scholar · View at Scopus
  23. J.-J. Lataillade, D. Clay, C. Dupuy et al., “Chemokine SDF-1 enhances circulating CD34+ cell proliferation in synergy with cytokines: possible role in progenitor survival,” Blood, vol. 95, no. 3, pp. 756–768, 2000. View at Google Scholar · View at Scopus
  24. J.-J. Lataillade, D. Clay, P. Bourin et al., “Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G0/G1 transition in CD34+ cells: evidence for an autocrine/paracrine mechanism,” Blood, vol. 99, no. 4, pp. 1117–1129, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Yu, M. Li, Z. Qu, D. Yan, D. Li, and Q. Ruan, “SDF-1/CXCR4-mediated migration of transplanted bone marrow stromal cells toward areas of heart myocardial infarction through activation of PI3K/Akt,” Journal of Cardiovascular Pharmacology, vol. 55, no. 5, pp. 496–505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Sotsios, G. C. Whittaker, J. Westwick, and S. G. Ward, “The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes,” The Journal of Immunology, vol. 163, no. 11, pp. 5954–5963, 1999. View at Google Scholar · View at Scopus
  27. M. R. Kano, Y. Morishita, C. Iwata et al., “VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRβ signaling,” Journal of Cell Science, vol. 118, no. 16, pp. 3759–3768, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. S.-W. Park, Y. Jun Koh, J. Jeon et al., “Efficient differentiation of human pluripotent stem cells into functional CD34+ progenitor cells by combined modulation of the MEK/ERK and BMP4 signaling pathways,” Blood, vol. 116, no. 25, pp. 5762–5772, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Yang, S.-W. Cho, S. M. Son et al., “Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 8, pp. 3317–3322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Hur, C.-H. Yoon, H.-S. Kim et al., “Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 2, pp. 288–293, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. E. M. Van Craenenbroeck, A. H. Van Craenenbroeck, S. Van Ierssel et al., “Quantification of circulating CD34+/KDR+/CD45 dim endothelial progenitor cells: analytical considerations,” International Journal of Cardiology, vol. 167, no. 5, pp. 1688–1695, 2013. View at Publisher · View at Google Scholar · View at Scopus